Clinical Trials Browser

Interventional × Linoleic Acids, Conjugated × Clear all

NCT00908791 2019-04-01

Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue

Phase EARLY_PHASE1 Completed

24 enrolled 10 charts

Breast Neoplasms

NCT00951158 2015-05-12

A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumors